Efficacy analysis of immunotherapy-based combinations for patients with EGFR-mutant advanced non-small cell lung cancer after TKI failure.

MLA

Meifang Li, et al. “Efficacy Analysis of Immunotherapy-Based Combinations for Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer after TKI Failure.” Oncology Letters, vol. 28, no. 5, Nov. 2024, pp. 1–10. EBSCOhost, https://doi.org/10.3892/ol.2024.14637.

APA

Meifang Li, Cheng Lin, Jinghui Lin, Shijie Chen, Lihong Weng, & Zhiyong He. (2024). Efficacy analysis of immunotherapy-based combinations for patients with EGFR-mutant advanced non-small cell lung cancer after TKI failure. Oncology Letters, 28(5), 1–10. https://doi.org/10.3892/ol.2024.14637

Chicago

Meifang Li, Cheng Lin, Jinghui Lin, Shijie Chen, Lihong Weng, and Zhiyong He. 2024. “Efficacy Analysis of Immunotherapy-Based Combinations for Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer after TKI Failure.” Oncology Letters 28 (5): 1–10. doi:10.3892/ol.2024.14637.